text.skipToContent text.skipToNavigation

Maximum quantity allowed is 999

Please select the quantity

CAS RN: 50-35-1 | Product Number: T2524

(±)-Thalidomide


Purity: >98.0%(HPLC)(N)
Synonyms:
  • N-(2,6-Dioxo-3-piperidinyl)phthalimide
Documents:
1G
£62.00
2   ≥20 
5G
£215.00
1   ≥20 

*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).


Product Number T2524
Purity / Analysis Method >98.0%(HPLC)(N)
Molecular Formula / Molecular Weight C__1__3H__1__0N__2O__4 = 258.23  
Physical State (20 deg.C) Solid
CAS RN 50-35-1
Reaxys Registry Number 30233
PubChem Substance ID 253662357
Merck Index (14) 9255
MDL Number

MFCD00153873

Specifications
Appearance White to Almost white powder to crystal
Purity(HPLC) min. 98.0 area%
Purity(with Total Nitrogen) min. 98.0 %
Properties (reference)
Melting Point 276 °C
Maximum Absorption Wavelength 300 nm
Solubility in water Insoluble
Degree of solubility in water 60 mg/l   25 °C
Solubility (very soluble in) Dimethylformamide,Dioxane
Solubility (very slightly) Methanol,Acetone,Ethanol
Solubility (insoluble in) Benzene,Ether,Chloroform
GHS
Pictogram Pictogram Pictogram
Signal Word Danger
Hazard Statements H301 : Toxic if swallowed.
H312 : Harmful in contact with skin.
H361 : Suspected of damaging fertility or the unborn child.
Precautionary Statements P201 : Obtain special instructions before use.
P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ protective clothing/ eye protection/ face protection.
P308 + P313 : IF exposed or concerned: Get medical advice/ attention.
P301 + P310 + P330 : IF SWALLOWED: Immediately call a POISON CENTER/doctor. Rinse mouth.
P302 + P352 + P312 : IF ON SKIN: Wash with plenty of water. Call a POISON CENTER/doctor if you feel unwell.
Related Laws: / Compliance with laws, Regulations
Enzyme Commission 200-031-1
RTECS# TI4375000
Transport Information:
UN Number UN2811
Class 6.1
Packing Group III
HS Number 2925199590
Application
Thalidomide: An Inhibitor of Angiogenesis

Thalidomide was originally used to treat morning sickness, but was banned as a human teratogen in the 1960s. In the 1990s, thalidomide has been discovered to have anti-inflammatory and anti-angiogenic properties, and is identified as an effective treatment for multiple myeloma. A recently approved amino analogue of thalidomide is pomalidomide [P2074]. (The product is for research purpose only.)

References


PubMed Literature


TCIMAIL
Documents
Safety Data Sheet (SDS) Search
Please select Language.

The requested SDS is not available.

• Please check that the Product Number you have entered is correct.

• If your information is correct and you are still not able to view the requested SDS,  please Contact Us for more information.

C of A & Other Certificates
Please enter Lot Number Incorrect Lot Number is entered
Other Documents